Global Medical Device Portfolio Compliance & EU MDR / FDA Regulation Updates
A global medical technology manufacturer with a portfolio of 450 class II and class III cardiovascular and orthopedic devices marketed across 35 countries.
Run on Parivart · Regulatory & Compliance
The challenge
Regulatory affairs teams monitored dozens of global health authority websites manually (FDA, EMA, NMPA, PMDA), missing critical guidance updates.
A new EU MDR clinical evaluation guidance revision required updates to 180 device Technical Files, but identifying affected product families took 6 weeks.
Delayed submission of updated regulatory filings risked product market withdrawal in key European territories.
How Parivart solves it
Global Health Authority Feed Ingestion
Parivart ingests and indexes real time regulatory notices, guidance documents, and safety bulletins from over 40 global regulatory agencies.
Automated Product Portfolio Mapping
Maps new regulatory clauses directly against active product Technical Files, device classification codes, and material formulations.
Clause Level Delta Impact Analysis
Highlights exact phrasing changes and new clinical evidence requirements between old and new regulation revisions.
Cross Functional Task Orchestration
Assigns compliance remediation actions to Clinical, Quality, and Regulatory leads with clear regulatory submission deadlines.
Audit Ready Compliance Trail
Maintains an immutable digital log of regulatory review decisions, impact assessments, and technical file updates.
The outcome
- regulatory change detection and impact analysis time cut
- 0 weeksregulatory change detection and impact analysis time cut
- reduced regulatory consulting and contractor spend
- $0reduced regulatory consulting and contractor spend
Regulatory change detection and impact analysis time cut from 6 weeks to 2 hours.
Zero product market withdrawals or license suspensions across all 35 global market jurisdictions.
Reduced regulatory consulting and contractor spend by $480,000 annually.
Representative scenario: a modelled industry situation showing how this accelerator applies. Figures are projections, not a named client result.
Capabilities used
Every accelerator is assembled from the same capability layer, so a workflow you adopt here shares its foundation with the rest of the portfolio.
More from Parivart
Quality & Compliance
Biopharmaceutical Multi Market Labeling & Safety Guideline Harmonization
A biopharmaceutical enterprise marketing monoclonal antibody therapies and oncology therapeutics across North America, Europe, Asia Pacific, and Latin America.
Safety & Security
Automotive Tier 1 Hazardous Material & Environmental Regulation Tracking
A Tier 1 global automotive supplier manufacturing cockpit electronics, sensors, and wiring harnesses for 12 automotive original equipment manufacturers (OEMs).
Quality & Compliance
Global Consumer Goods Ingredient Safety & Formulation Standard Compliance
A multinational personal care and cosmetics brand producing skincare, hair care, and fragrance products distributed in 60 international markets.
Bring us the version of this that you actually have.
Every engagement is fixed-scope and outcome-guaranteed. The scoping conversation starts with your systems, not with a template.